دورية أكاديمية
The efficacy of sour tea (Hibiscus sabdariffa L.) on selected cardiovascular disease risk factors: A systematic review and meta-analysis of randomized clinical trials.
العنوان: | The efficacy of sour tea (Hibiscus sabdariffa L.) on selected cardiovascular disease risk factors: A systematic review and meta-analysis of randomized clinical trials. |
---|---|
المؤلفون: | Najafpour Boushehri S; Department of Nutrition, Faculty of Health and Nutrition, Bushehr University of Medical Sciences, Bushehr, Iran., Karimbeiki R; Department of Clinical Nutrition, School of Nutrition & Food Science, Isfahan University of Medical Sciences, Isfahan, Iran., Ghasempour S; Department of Nutrition, Lorestan University of Medical Sciences, Khorramabad, Iran., Ghalishourani SS; Department of Physical Education and Sport Science, Science and Research Branch, Islamic Azad University, Tehran, Iran., Pourmasoumi M; Food Security Research Center and Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.; Universal Scientific Education and Research Network (USERN), Tehran, Iran., Hadi A; Halal Research Center of IRI, FDA, Tehran, Iran., Mbabazi M; Nutrisat Uganda and Department of Human Nutrition and Dietetics, Victoria University, Kampala, Uganda., Pour ZK; Department of Nutrition, Faculty of Health and Nutrition, Bushehr University of Medical Sciences, Bushehr, Iran., Assarroudi M; Torbat Jam Faculty of Medical Sciences, Torbat-e Jam, Iran., Mahmoodi M; Department of Biostatistics, Faculty of Health and Nutrition, Bushehr University of Medical Sciences, Bushehr, Iran., Khosravi A; Medical Library and Information Science Department, Bushehr University of Medical Sciences, Bushehr, Iran., Mansour-Ghanaei F; GI Cancer Screening & Prevention Research Center, Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran., Joukar F; Caspian Digestive Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran. |
المصدر: | Phytotherapy research : PTR [Phytother Res] 2020 Feb; Vol. 34 (2), pp. 329-339. Date of Electronic Publication: 2020 Jan 14. |
نوع المنشور: | Journal Article; Meta-Analysis; Systematic Review |
اللغة: | English |
بيانات الدورية: | Publisher: Wiley Country of Publication: England NLM ID: 8904486 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1573 (Electronic) Linking ISSN: 0951418X NLM ISO Abbreviation: Phytother Res Subsets: MEDLINE |
أسماء مطبوعة: | Publication: Original Publication: London : Heyden & Son, c1987- |
مواضيع طبية MeSH: | Blood Glucose/*drug effects , Blood Pressure/*drug effects , Cardiovascular Diseases/*prevention & control , Hibiscus/*chemistry , Plant Extracts/*pharmacology, Cholesterol, HDL/blood ; Humans ; Randomized Controlled Trials as Topic ; Risk Factors ; Tea ; Triglycerides/blood |
مستخلص: | This study sought to summarize clinical evidence of sour tea (Hibiscus sabdariffa L.) administration on cardiovascular disease risk factors. PubMed, Scopus, Institute for Scientific Information Web of Science, and Google Scholar were systematically searched from inception to June 2019 to identify randomized clinical trials, which assessed the effect of sour tea consumption on lipid profiles, fasting plasma glucose, and blood pressure in adult populations. Mean and standard deviation for each parameter were extracted to calculate effect size. Cochrane Collaboration tools were used to evaluate risk of bias assessment. A total of seven randomized clinical trials consisting 362 participants were included in the meta-analysis. Pooled effect size demonstrated that sour tea consumption significantly reduces fasting plasma glucose (-3.67 mg/dl, 95% confidence interval, CI [-7.07, -0.27]; I 2 = 37%), systolic blood pressure (-4.71 mmHg, 95% CI [-7.87, -1.55]; I 2 = 53%), and diastolic blood pressure (-4.08 mmHg, 95% CI [-6.48, -1.67]; I 2 = 14%). Although no significant effect was observed on triacylglycerol, total cholesterol, and high-density lipoprotein cholesterol following sour tea consumption, a trend toward a significant reduction was found in low-density lipoprotein cholesterol serum concentrations (p = 0.08). This systematic review and meta-analysis suggests that sour tea consumption could have beneficial effect in controlling glycemic status and blood pressure among adult population. (© 2020 John Wiley & Sons, Ltd.) |
References: | Adegunloye, B., Omoniyi, J., Owolabi, O., Ajagbonna, O., Sofola, O., & Coker, H. (1996). Mechanisms of the blood pressure lowering effect of the calyx extract of Hibiscus sabdariffa in rats. African Journal of Medicine and Medical Sciences, 25(3), 235-238. Ajay, M., Chai, H., Mustafa, A., Gilani, A. H., & Mustafa, M. R. (2007). Mechanisms of the anti-hypertensive effect of Hibiscus sabdariffa L. calyces. Journal of Ethnopharmacology, 109(3), 388-393. https://doi.org/10.1016/j.jep.2006.08.005. Alabousi, M., Abdullah, P., Alter, D. A., Booth, G. L., Hogg, W., Ko, D. T., … Udell, J. A. (2017). Cardiovascular risk factor management performance in Canada and the United States: A systematic review. Canadian Journal of Cardiology, 33(3), 393-404. https://doi.org/10.1016/j.cjca.2016.07.005. Ali, B. H., Wabel, N. A., & Blunden, G. (2005). Phytochemical, pharmacological and toxicological aspects of Hibiscus sabdariffa L.: A review. Phytotherapy Research, 19(5), 369-375. https://doi.org/10.1002/ptr.1628. Asgary, S., Soltani, R., Zolghadr, M., Keshvari, M., & Sarrafzadegan, N. (2016). Evaluation of the effects of roselle (Hibiscus sabdariffa L.) on oxidative stress and serum levels of lipids, insulin and hs-CRP in adult patients with metabolic syndrome: A double-blind placebo-controlled clinical trial. Journal of Complementary and Integrative Medicine, 13(2), 175-180. https://doi.org/10.1515/jcim-2015-0030. Aziz, Z., Wong, S. Y., & Chong, N. J. (2013). Effects of Hibiscus sabdariffa L. on serum lipids: A systematic review and meta-analysis. Journal of Ethnopharmacology, 150(2), 442-450. Bahmani, M., Mirhoseini, M., Shirzad, H., Sedighi, M., Shahinfard, N., & Rafieian-Kopaei, M. (2015). A review on promising natural agents effective on hyperlipidemia. J Evid Based Complementary Altern Med, 20(3), 228-238. https://doi.org/10.1177/2156587214568457. Bahramsoltani, R., Farzaei, M. H., & Rahimi, R. (2017). Herbal remedies for atherosclerosis: From back to the future. Cardiovascular Diseases, 1, 188. Balakumar, P., Maung-U, K., & Jagadeesh, G. (2016). Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacological Research, 113, 600-609. https://doi.org/10.1016/j.phrs.2016.09.040. Caballero-George, C., Vanderheyden, P. M., De Bruyne, T., Shahat, A.-A., Van den Heuvel, H., Solis, P. N., … Vauquelin, G. (2002). In vitro inhibition of [3H]-angiotensin II binding on the human AT1 receptor by proanthocyanidins from Guazuma ulmifolia bark. Planta Medica, 68(12), 1066-1071. https://doi.org/10.1055/s-2002-36344. Carvajal-Zarrabal, O., Waliszewski, S. M., Barradas-Dermitz, D. M., Orta-Flores, Z., Hayward-Jones, P. M., Nolasco-Hipólito, C., … Trujillo, P. R. (2005). The consumption of Hibiscus sabdariffa dried calyx ethanolic extract reduced lipid profile in rats. Plant Foods for Human Nutrition, 60(4), 153. Chang, H.-C., Peng, C.-H., Yeh, D.-M., Kao, E.-S., & Wang, C.-J. (2014). Hibiscus sabdariffa extract inhibits obesity and fat accumulation, and improves liver steatosis in humans. Food & Function, 5(4), 734-739. Chen, C.-C., Hsu, J.-D., Wang, S.-F., Chiang, H.-C., Yang, M.-Y., Kao, E.-S., … Wang, C.-J. (2003). Hibiscus sabdariffa extract inhibits the development of atherosclerosis in cholesterol-fed rabbits. Journal of Agricultural and Food Chemistry, 51(18), 5472-5477. https://doi.org/10.1021/jf030065w. Da-Costa-Rocha, I., Bonnlaender, B., Sievers, H., Pischel, I., & Heinrich, M. (2014). Hibiscus sabdariffa L.-A phytochemical and pharmacological review. Food Chemistry, 165, 424-443. https://doi.org/10.1016/j.foodchem.2014.05.002. Dersimonian, R., & Laird, N. Meta-analysis in clinical trials. ControlClin Trials 1986; 7: 177-88. In: DOl https://doi.org/10.1016/0197-2456(86)90046-2. Doughty, K. N., Del Pilar, N. X., Audette, A., & Katz, D. L. (2017). Lifestyle medicine and the management of cardiovascular disease. Current Cardiology Reports, 19(11), 116. https://doi.org/10.1007/s11886-017-0925-z. Duangjai, A., Ingkaninan, K., & Limpeanchob, N. (2011). Potential mechanisms of hypocholesterolaemic effect of Thai spices/dietary extracts. Natural Product Research, 25(4), 341-352. Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315(7109), 629-634. https://doi.org/10.1136/bmj.315.7109.629. Fakeye, T. O., Pal, A., Bawankule, D., Yadav, N., & Khanuja, S. (2009). Toxic effects of oral administration of extracts of dried calyx of Hibiscus sabdariffa Linn. (Malvaceae). Phytotherapy Research, 23(3), 412-416. https://doi.org/10.1002/ptr.2644. Fakhrzadeh, H., & Tabatabaei-Malazy, O. (2012). Dyslipidemia and cardiovascular disease. In Dyslipidemia-From prevention to treatment: InTech. Formagio, A., Ramos, D., Vieira, M., Ramalho, S., Silva, M., Zárate, N., … Carvalho, J. (2015). Phenolic compounds of Hibiscus sabdariffa and influence of organic residues on its antioxidant and antitumoral properties. Brazilian Journal of Biology, 75(1), 69-76. Gurrola-Díaz, C., Garcia-Lopez, P., Sánchez-Enríquez, S., Troyo-Sanromán, R., Andrade-González, I., & Gómez-Leyva, J. (2010). Effects of Hibiscus sabdariffa extract powder and preventive treatment (diet) on the lipid profiles of patients with metabolic syndrome (MeSy). Phytomedicine, 17(7), 500-505. https://doi.org/10.1016/j.phymed.2009.10.014. Hadi, A., Pourmasoumi, M., Kafeshani, M., Karimian, J., Maracy, M. R., & Entezari, M. H. (2017). The effect of green tea and sour tea (Hibiscus sabdariffa L.) supplementation on oxidative stress and muscle damage in athletes. Journal of Dietary Supplements, 14(3), 346-357. Hadi, A., Pourmasoumi, M., Mohammadi, H., Javaheri, A., & Rouhani, M. H. (2019). The impact of pycnogenol supplementation on plasma lipids in humans: A systematic review and meta-analysis of clinical trials. Phytotherapy Research, 33(2), 276-287. Hajifaraji, M., Matlabi, M., Ahmadzadeh-Sani, F., Mehrabi, Y., Rezaee, M. S., Hajimehdipour, H., … Roghani, K. (2018). Effects of aqueous extracts of dried calyx of sour tea (Hibiscus sabdariffa L.) on polygenic dyslipidemia: A randomized clinical trial. Avicenna Journal of Phytomedicine, 8(1), 24-32. Hasani, H., Arab, A., Hadi, A., Pourmasoumi, M., Ghavami, A., & Miraghajani, M. (2019). Does ginger supplementation lower blood pressure? A systematic review and meta-analysis of clinical trials. Phytotherapy Research, 33, 1639-1647. https://doi.org/10.1002/ptr.6362. Heidenreich, P. A., Trogdon, J. G., Khavjou, O. A., Butler, J., Dracup, K., Ezekowitz, M. D., … Woo, Y. J. (2011). Forecasting the future of cardiovascular disease in the United States: A policy statement from the American Heart Association. Circulation, 123(8), 933-944. https://doi.org/10.1161/CIR.0b013e31820a55f5. Hernández-Pérez, F., & Herrera-Arellano, A. (2011). Therapeutic use Hibiscus sabadariffa extract in the treatment of hypercholesterolemia. A randomized clinical trial. Revista Médica del Instituto Mexicano del Seguro Social, 49(5), 469-480. Herrera-Arellano, A., Flores-Romero, S., Chavez-Soto, M., & Tortoriello, J. (2004). Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: A controlled and randomized clinical trial. Phytomedicine, 11(5), 375-382. https://doi.org/10.1016/j.phymed.2004.04.001. Herrera-Arellano, A., Miranda-Sánchez, J., Ávila-Castro, P., Herrera-Álvarez, S., Jiménez-Ferrer, J. E., Zamilpa, A., … Tortoriello, J. (2007). Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinopril-controlled clinical trial. Planta Medica, 73(01), 6-12. Higgins, J. P. T., Altman, D. G., Gøtzsche, P. C., Jüni, P., Moher, D., Oxman, A. D., … Sterne, J. A. C. (2011). The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. The BMJ, 343, d5928. https://doi.org/10.1136/bmj.d5928. Johnson, S. S., Oyelola, F. T., Ari, T., & Juho, H. (2013). In vitro inhibitory activities of the extract of Hibiscus sabdariffa L. (family Malvaceae) on selected cytochrome P450 isoforms. African Journal of Traditional, Complementary, and Alternative Medicines, 10(3), 533-540. Kafeshani, M., Entezari, M. H., Karimian, J., Pourmasoumi, M., Maracy, M. R., Amini, M. R., & Hadi, A. (2017). A comparative study of the effect of green tea and sour tea on blood pressure and lipid profile in healthy adult men. ARYA Atheroscler, 13(3), 109-116. Karimian, J., Hadi, A., Pourmasoumi, M., Najafgholizadeh, A., & Ghavami, A. (2019). The efficacy of propolis on markers of glycemic control in adults with type 2 diabetes mellitus: A systematic review and meta-analysis. Phytotherapy Research, 33, 1616-1626. https://doi.org/10.1002/ptr.6356. Kuriyan, R., Kumar, D. R., Rajendran, R., & Kurpad, A. V. (2010). An evaluation of the hypolipidemic effect of an extract of Hibiscus sabdariffa leaves in hyperlipidemic Indians: A double blind, placebo controlled trial. BMC Complementary and Alternative Medicine, 10(1), 27. Levitan, E. B., Song, Y., Ford, E. S., & Liu, S. (2004). Is nondiabetic hyperglycemia a risk factor for cardiovascular disease?: A meta-analysis of prospective studies. Archives of Internal Medicine, 164(19), 2147-2155. https://doi.org/10.1001/archinte.164.19.2147. Mahmoud, Y. I. (2012). Effect of extract of Hibiscus on the ultrastructure of the testis in adult mice. Acta Histochemica, 114(4), 342-348. https://doi.org/10.1016/j.acthis.2011.07.002. McKay, D. L., Chen, C. O., Saltzman, E., & Blumberg, J. B. (2009). Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults. The Journal of Nutrition, 140(2), 298-303. https://doi.org/10.3945/jn.109.115097. Mendis, S. (2017). Global progress in prevention of cardiovascular disease. Cardiovascular Diagnosis and Therapy, 7(Suppl 1), S32. Mohammadi, A., Sahebkar, A., Iranshahi, M., Amini, M., Khojasteh, R., Ghayour-Mobarhan, M., & Ferns, G. A. (2013). Effects of supplementation with curcuminoids on dyslipidemia in obese patients: A randomized crossover trial. Phytotherapy Research, 27(3), 374-379. https://doi.org/10.1002/ptr.4715. Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & Group, P. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6(7), e1000097. https://doi.org/10.1371/journal.pmed.1000097. Mojiminiyi, F., Adegunloye, B., Egbeniyi, Y., & Okolo, R. (2000). An investigation of the diuretic effect of an aqueous extract of the petals of Hibiscus sabdariffa. Mozaffari-Khosravi, H., Ahadi, Z., & Tafti, M. F. (2014). The effect of green tea versus sour tea on insulin resistance, lipids profiles and oxidative stress in patients with type 2 diabetes mellitus: A randomized clinical trial. Iranian Journal of Medical Sciences, 39(5), 424. Mozaffari-Khosravi, H., Jalali-Khanabadi, B.-A., Afkhami-Ardekani, M., & Fatehi, F. (2009). Effects of sour tea (Hibiscus sabdariffa) on lipid profile and lipoproteins in patients with type II diabetes. The Journal of Alternative and Complementary Medicine, 15(8), 899-903. https://doi.org/10.1089/acm.2008.0540. Ndu, O. O., Nworu, C. S., Ehiemere, C. O., Ndukwe, N. C., & Ochiogu, I. S. (2011). Herb-drug interaction between the extract of Hibiscus sabdariffa L. and hydrochlorothiazide in experimental animals. Journal of Medicinal Food, 14(6), 640-644. https://doi.org/10.1089/jmf.2010.0117. Nwachukwu, D., Aneke, E., Nwachukwu, N., Obika, L., Nwagha, U., & Eze, A. (2015). Effect of Hibiscus sabdariffa on blood pressure and electrolyte profile of mild to moderate hypertensive Nigerians: A comparative study with hydrochlorothiazide. Nigerian Journal of Clinical Practice, 18(6), 762-770. https://doi.org/10.4103/1119-3077.163278. Nwachukwu, D. C., Aneke, E. I., Obika, L. F., & Nwachukwu, N. Z. (2015). Effects of aqueous extract of Hibiscus sabdariffa on the renin-angiotensin-aldosterone system of Nigerians with mild to moderate essential hypertension: A comparative study with lisinopril. Indian Journal of Pharmacology, 47(5), 540-545. https://doi.org/10.4103/0253-7613.165194. Onyenekwe, P., Ajani, E., Ameh, D., & Gamaniel, K. (1999). Antihypertensive effect of roselle (Hibiscus sabdariffa) calyx infusion in spontaneously hypertensive rats and a comparison of its toxicity with that in Wistar rats. Cell Biochemistry and Function, 17(3), 199-206. https://doi.org/10.1002/(SICI)1099-0844(199909)17:3<199::AID-CBF829>3.0.CO;2-2. Patel, S. (2014). Hibiscus sabdariffa: An ideal yet under-exploited candidate for nutraceutical applications. Biomedicine & Preventive Nutrition, 4(1), 23-27. Pourmasoumi, M., Hadi, A., Najafgholizadeh, A., Joukar, F., & Mansour-Ghanaei, F. (2019). The effects of cranberry on cardiovascular metabolic risk factors: A systematic review and meta-analysis. Clinical Nutrition. Ridker, P. M. (2014). LDL cholesterol: Controversies and future therapeutic directions. The Lancet, 384(9943), 607-617. Sabzghabaee, A. M., Ataei, E., Kelishadi, R., Ghannadi, A., Soltani, R., Badri, S., & Shirani, S. (2013). Effect of Hibiscus sabdariffa calices on dyslipidemia in obese adolescents: A triple-masked randomized controlled trial. Materia socio-medica, 25(2), 76-79. https://doi.org/10.5455/msm.2013.25.76-79. Sahebkar, A., Serban, C., Dragan, S., Urosniu, S., Florina, A., Rysz, J., & Banach, M. (2015). Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension: A systematic review and meta-analysis of randomized controlled trials. Atherosclerosis, 241(1), e190-e191. Seck, S. M., Doupa, D., Dia, D. G., Diop, E. A., Ardiet, D.-L., Nogueira, R. C., … Diouf, B. (2018). Clinical efficacy of African traditional medicines in hypertension: A randomized controlled trial with Combretum micranthum and Hibiscus sabdariffa. Journal of Human Hypertension, 32(1), 75-81. https://doi.org/10.1038/s41371-017-0001-6. Serban, C., Sahebkar, A., Ursoniu, S., Andrica, F., & Banach, M. (2015). Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension: A systematic review and meta-analysis of randomized controlled trials. Journal of Hypertension, 33(6), 1119-1127. https://doi.org/10.1097/hjh.0000000000000585. Shi, C., Karim, S., Wang, C., Zhao, M., & Murtaza, G. (2014). A review on antidiabetic activity of Citrullus colocynthis Schrad. Acta Poloniae Pharmaceutica, 71(3), 363-367. Sindi, H. A., Marshall, L. J., & Morgan, M. R. (2014). Comparative chemical and biochemical analysis of extracts of Hibiscus sabdariffa. Food Chemistry, 164, 23-29. Siu, A. L. (2015). Screening for high blood pressure in adults: US Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 163(10), 778-786. https://doi.org/10.7326/M15-2223. Soleimani, A.-R., Akbari, H., Soleimani, S., Mousavi, S. S. B., & Tamadon, M.-R. (2015). Effect of sour tea (Lipicom) pill versus captopril on the treatment of hypertension. Journal of Renal Injury Prevention, 4(3), 73-79. https://doi.org/10.12861/jrip.2015.15. Sterne, J., & Bradburn, M. (2001). Meta-analysis in Stata. In M. Egger, G. Smith, & D. Altman (Eds.), Systematic reviews in health care (pp. 347-372). 2 London: BMJ Publishing Group. Thorlund, K., Engstrøm, J., Wetterslev, J., Brok, J., Imberger, G., & Gluud, C. (2011). User manual for trial sequential analysis (TSA). Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen, Denmark, 1, 1-115. Tibebu, A., Mengistu, D., & Negesa, L. (2017). Adherence to recommended lifestyle modifications and factors associated for hypertensive patients attending chronic follow-up units of selected public hospitals in Addis Ababa, Ethiopia. Patient Preference and Adherence, 11, 323-330. https://doi.org/10.2147/PPA.S126382. World Health Organization May (2017). Cardiovascular diseases (CVDs). Retrieved from http://www.who.int/mediacentre/factsheets/fs317/en/. Yang, M.-Y., Peng, C.-H., Chan, K.-C., Yang, Y.-S., Huang, C.-N., & Wang, C.-J. (2009). The hypolipidemic effect of Hibiscus sabdariffa polyphenols via inhibiting lipogenesis and promoting hepatic lipid clearance. Journal of Agricultural and Food Chemistry, 58(2), 850-859. |
فهرسة مساهمة: | Keywords: Hibiscus sabdariffa; Rosella; blood pressure; cardiovascular disease; fasting plasma glucose; lipid profile |
المشرفين على المادة: | 0 (Blood Glucose) 0 (Cholesterol, HDL) 0 (Plant Extracts) 0 (Tea) 0 (Triglycerides) |
تواريخ الأحداث: | Date Created: 20200117 Date Completed: 20200430 Latest Revision: 20200430 |
رمز التحديث: | 20221213 |
DOI: | 10.1002/ptr.6541 |
PMID: | 31943427 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1099-1573 |
---|---|
DOI: | 10.1002/ptr.6541 |